Literature DB >> 23329521

Pneumonectomy with and without induction chemo-radiotherapy for non-small cell lung cancer: short and long-term results from a single centre.

S Margaritora1, A Cesario, G Cusumano, V Dall'armi, V Porziella, E Meacci, F Lococo, R D'Angelillo, M T Congedo, P Granone.   

Abstract

BACKGROUND AND OBJECTIVES: Pneumonectomy for non small cell lung cancer (NSCLC) after induction radio-chemotherapy (IT) has been associated with high peri-operative risk and its safety and efficacy is still debated. The aim of this retrospective study was to compare short and long-term results of pneumonectomy in patients treated with and without IT (radiotherapy plus chemotherapy) for NSCLC.
MATERIALS AND METHODS: From 1995 to 2008, 85 consecutive patients underwent pneumonectomy: 49 received pre-operative radiotherapy and chemotherapy (IT group), and 36 patients did not (non-IT group). Peri-operative and long-term outcomes were compared.
RESULTS: Major complications rate was 14.3% for IT group and 16.7% for non-IT group (p = n.s.). Mortality rate was 2% in IT group and 5.5% in non-IT group (p = n.s.). Post-operative hospital stay was significantly longer in the IT group (p < 0.0001) as the need for blood transfusion (p = 0.002). Indeed, the mortality rate was similar in the left- and right-sided operations. 5 years survival was 45.3% for IT group and 38.4% for non-IT group (p = n.s.) and 5 year disease free survival rates were 42.3% vs. 37.8% for the two groups, respectively (p = n.s.). Among the clinical, surgical and pathological features no differences on long term outcomes were found with regards to IT. DISCUSSION: Pneumonectomy is a feasible and safe procedure even after pre-operative IT. Our results showed a prolonged hospitalization and the need for blood transfusion in the IT group.

Entities:  

Mesh:

Year:  2013        PMID: 23329521

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

Review 1.  [Consequences of pneumonectomy in the early and late phases].

Authors:  R A Hatz; L V Klotz
Journal:  Chirurg       Date:  2013-06       Impact factor: 0.955

2.  Three-dimensional conformal intensity-modulated radiation therapy of left femur foci does not damage the sciatic nerve.

Authors:  Wanlong Xu; Xibin Zhao; Qing Wang; Jungang Sun; Jiangbo Xu; Wenzheng Zhou; Hao Wang; Shigui Yan; Hong Yuan
Journal:  Neural Regen Res       Date:  2014-10-15       Impact factor: 5.135

3.  Comprehensive study of prognostic risk factors of patients underwent pneumonectomy.

Authors:  Chang Gu; Rui Wang; Xufeng Pan; Qingyuan Huang; Jizhuang Luo; Jiajie Zheng; Yiyang Wang; Jianxin Shi; Haiquan Chen
Journal:  J Cancer       Date:  2017-07-05       Impact factor: 4.207

Review 4.  Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer.

Authors:  Branislav Jeremić; Francesc Casas; Pavol Dubinsky; Antonio Gomez-Caamano; Nikola Čihorić; Gregory Videtic; Ivan Igrutinovic
Journal:  Front Oncol       Date:  2018-02-20       Impact factor: 6.244

5.  Evaluation of different treatment strategies between right-sided and left-sided pneumonectomy for stage I-IIIA non-small cell lung cancer patients.

Authors:  Bo Jia; Qiwen Zheng; Jianjie Li; Jun Zhao; Meina Wu; Tongtong An; Yuyan Wang; Minglei Zhuo; Xue Yang; Hanxiao Chen; Yujia Chi; Jingjing Wang; Xiaoyu Zhai; Yuling He; Lingdong Kong; Ziping Wang
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 3.005

6.  Safe pneumonectomy for locally advanced lung cancer after induction therapy.

Authors:  Tetsuhiko Go; Toshihiro Ikeda; Naoya Yokota; Atsushi Fujiwara; Yasuhiro Otsuki; Ayumu Kato; Sung Soo Chang; Noriyuki Misaki; Dage Liu; Hiroyasu Yokomise
Journal:  Surg Today       Date:  2021-07-27       Impact factor: 2.549

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.